MariaKramarczukHordinskyMD

Dermatology • Minneapolis, MN

Physician

Join to view full profile

Dr. Hordinsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hordinsky's full profile

Already have an account?

Office
516 Delaware Street Se, Clinic 5a
Dermatology Clinic
Minneapolis, MN 55455
Phone+1 612-625-5656

Fax+1 612-672-7422

Education & Training

University of MinnesotaResidency, Dermatology, 1977 - 1980
Henry Ford Health/Henry Ford HospitalInternship, Internal Medicine, 1976 - 1977
University of North Dakota School of Medicine and Health SciencesClass of 1976

Certifications & Licensure

MN State Medical License 1980 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

Alopecia Areata Registry Start of enrollment: 2001 Nov 01
Active, not recruiting
Alefacept in Patients With Severe Scalp Alopecia Areata Start of enrollment: 2005 Jul 01
Completed
Not Applicable
Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% Start of enrollment: 2000 Oct 01
Completed
Phase 4
Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients Start of enrollment: 2002 Nov 01
Terminated
Phase 3
Response of Topical Capsaicin in Alopecia Areata Start of enrollment: 1997 Aug 01
Completed
Phase 4
Plaquenil for Alopecia Areata, Alopecia Totalis Start of enrollment: 2002 Apr 01
Completed
Phase 4
Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae Start of enrollment: 1999 Mar 01
Completed
Phase 2
Aldara for the Treatment of Extensive Alopecia Areata Start of enrollment: 2000 Oct 01
Completed
Phase 4
Topical Hydromorphone for Wound Healing Start of enrollment: 2003 Oct 01
Terminated
Phase 1, Phase 2
Alopecia Areata Registry and Immunogenetic Mechanisms Start of enrollment: 2001 Sep 01
Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice Start of enrollment: 2003 Jul 01
Completed
Phase 1
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata Start of enrollment: 2007 May 01
Completed
Phase 2
Use of Botulinum Toxin to Treat Psoriasis Start of enrollment: 2009 Jan 01
Completed
Phase 1
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma Start of enrollment: 2008 Dec 01
Terminated
Phase 1, Phase 2
Treatment of Androgenetic Alopecia in Females, 12 Beam Start of enrollment: 2010 Jan 01
Completed
Not Applicable
Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata Start of enrollment: 2009 Mar 01
Completed
Phase 2
Intralesional Steroids in the Treatment of Alopecia Areata Start of enrollment: 2011 Sep 01
Terminated
Phase 4
Treatment of Chronic Itch in Atopic Dermatitis (Eczema): Nerve Function Start of enrollment: 2015 Jul 01
Completed
Phase 1
Platelet Rich Plasma for Frontal Fibrosing Alopecia Start of enrollment: 2025 Mar 01
Not yet recruiting
Not Applicable
Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia Start of enrollment: 2016 Jan 28
Completed
Early Phase 1
DPCP for the Treatment of Alopecia Areata Start of enrollment: 2024 Apr 01
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

549 citations
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
Lynn Petukhova, Madeleine Duvic, Maria K. Hordinsky, David A. Norris, Vera H. Price
Nature. 2010-07-01
124 citations
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Lynn A. Drake, Maria K. Hordinsky, Virginia C. Fiedler, James M. Swinehart, Walter P. Unger
Journal of the American Academy of Dermatology. 1999-10-01
32 citations
A systemic type I 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris
James J. Leyden, Wilma F. Bergfeld, Lynn A. Drake, Frank Dunlap, Mitchel P. Goldman
Journal of the American Academy of Dermatology. 2004-03-01

Lectures

Closing the Gender Gap in Academic Dermatology and Dermatology Leadership: Problems and Solutions
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
Women's & Pediatric Dermatology Seminar 2013
Global Academy for Medical Education (Elsevier), Newport Beach, California - 10/4/2013
Women's & Pediatric Dermatology Seminar 2013
Global Academy for Medical Education (Elsevier), Newport Beach, California - 10/4/2013
Dermatology 2013: Discoveries and Advances
University of Minnesota, Minneapolis, Minnesota - 5/17/2013
Practical Dermatology: Basic and Advanced Topics for Primary Care
University of Minnesota, Duluth, Minnesota - 10/26/2012
Women's and Pediatric Dermatology Seminar 2012
Global Academy for Medical Education (Elsevier), San Francisco, California - 10/19/2012
Skin Disease Education Foundation Women's & Pediatrics Dermatology Seminar
Global Academy for Medical Education (Elsevier), San Francisco, California - 10/19/2012
Pediatric Dermatology Progress and Practices
University of Minnesota, Minneapolis, Minnesota - 5/18/2012
Join now to see all

Press Mentions

Frontal Fibrosing Alopecia PathogenesisMarch 22nd, 2023
2022 Top Doctors, Rising Stars Edition: Care That Transforms LivesApril 1st, 2022
Dramatic, Durable Hair Growth with Oral JAK InhibitorMarch 27th, 2022
Join now to see all

MariaKramarczukHordinskyMD

Dr. Hordinsky is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.